Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 1,775 | 1,448 | 5,887 | 2,729 | 1,454 |
| Cost of Goods | N/A | N/A | 1,399 | N/A | N/A |
| Gross Profit | 1,775 | 1,448 | 4,488 | 2,729 | 1,454 |
| Operating Expenses | 36,873 | 36,366 | 34,217 | 27,991 | 29,947 |
| Operating Income | -35,098 | -34,918 | -29,330 | -25,262 | -28,493 |
| Interest Expense | 3,044 | 3,035 | 2,726 | 2,414 | 2,346 |
| Other Income | 550 | 324 | 1,002 | 244 | 1,242 |
| Pre-tax Income | -37,592 | -37,629 | -31,054 | -27,432 | -29,597 |
| Net Income Continuous | -37,592 | -37,629 | -31,054 | -27,432 | -29,597 |
| Net Income | $-37,592 | $-37,629 | $-31,054 | $-27,432 | $-29,597 |
| EPS Basic Total Ops | -0.34 | -0.34 | -0.28 | -0.25 | -0.28 |
| EPS Basic Continuous Ops | -0.34 | -0.34 | -0.28 | -0.25 | -0.28 |
| EPS Diluted Total Ops | -0.34 | -0.34 | -0.28 | -0.25 | -0.28 |
| EPS Diluted Continuous Ops | -0.34 | -0.34 | -0.28 | -0.25 | -0.28 |
| EBITDA(a) | $-34,558 | $-34,351 | $-28,961 | $-24,897 | $-28,065 |